| 1. | asheymommy | |
| 2. | marz11 | |
| 3. | dynamichealthsol | |
| 4. | franciscaguila78 | |
| 5. | badaleyes |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | dynamichealthsol 02/02/2018 Beats EPS estimates by $0.04. |
| 2. | badaleyes 02/02/2018 Big news - Sees FY18 revs $41.2-42.7 bln vs $41.10 bln |
| 3. | asheymommy 03/01/2018 News |
| 4. | franciscaguila78 05/04/2018 Moderna and Merck Expand mRNA Cancer Vaccines Collaboration |
| 5. | marz11 04/10/2018 Merck monotherapy met primary endpoint in phase 3 keynote-042 study, significantly improving OS as first-line… |
| 6. | dynamichealthsol 01/03/2018 er details |
| 7. | franciscaguila78 06/25/2018 FDA accepts supplemental biologics license application for Merck’s KEYTRUDA |
| 8. | marz11 06/25/2018 Presents new data for Sitagliptin Program with JANUVIA |
| 9. | dynamichealthsol 02/21/2018 Merck and Viralytics Announce Acquisition Agreement, Expanding Merck's Leading Immuno-Oncology Pipeline |
| 10. | dynamichealthsol 04/16/2018 Merck's KEYTRUDA® (pembrolizumab) Plus Pemetrexed (ALIMTA®) and Platinum Chemotherapy Reduced the Risk of Death by Half Compared with Chemotherapy Alone as First-Line Treatment for Advanced Nonsquamou |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Merck & Company, Inc.
- MRK
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.